MedTrace Logo

Evaluation of Stenfilcon A Versus Etafilcon A

NCT01809834 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2020-07-28

Study results available
· View outcomes & findings →

Summary

Evaluation of two contact lenses

Conditions

  • Myopia

Interventions

DEVICE

Etafilcon A

DEVICE

Stenfilcon A

Sponsors & Collaborators

  • CooperVision, Inc.

    lead INDUSTRY

Principal Investigators

  • Lyndon Jones, PhD., FCO · Univeristy of Waterloo, Canada

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2013-02-28
Completion
2013-11-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01809834 on ClinicalTrials.gov